Italy· 025575059
LIMICAN*4 fiale IM EV 50 mg 2 ml
A alizapride product containing alizapride, registered in Italy by ACARPIA FARMACEUTICI Srl, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Alizapride is registered in 3 of 19 countries.
Countries holding a registration under ATC A03FA05 (alizapride), each read from that country’s own register.
- This record: Italy
- 3 of them publish a price we can compare per daily dose
Alizapride · ATC A03FA05
3 / 19 countries
- Belgiumprice
- Italyprice
- Norwayprice
The record
At a glance
- Active substance
- Alizapride
- Manufacturer
- ACARPIA FARMACEUTICI Srl
- Country
- Italy (IT)
- ATC code
- A03FA05
- ATC class
- Alizapride
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic025575059LIMICAN*4 fiale IM EV 50 mg 2 mlEUR 4.03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alizapride in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLitican 12 mg/mlSanofi Belgium
- FrancePLITICAN, solution injectableSANOFI WINTHROP INDUSTRIE
- NorwayLiticansanofi-aventis (2)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Belgium · Litican
- France · Plitican
- Luxembourg · Litican
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a0f14a7c-5060-45e7-851d-ff5b69567a00 GET /v1/drugs/a0f14a7c-5060-45e7-851d-ff5b69567a00?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4.03,
"source": "aifa",
"currency": "EUR",
"strength": "ALIZAPRIDE 50MG 2ML 4 UNITA' USO PARENTERALE",
"substance": "Alizapride",
"equivalence_group": "LLJ",
"transparency_flag": null
}See everything about alizapride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.